Trial Profile
Symbicort [budesonide/formoterol] in chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Feb 2011
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms SYMBOL
- Sponsors AstraZeneca
- 11 Mar 2008 New trial record.